Europe & Central Asia (IDA & IBRD countries) | Immunization, HepB3 (% of one-year-old children)

Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Europe & Central Asia (IDA & IBRD countries)
Records
63
Source
Europe & Central Asia (IDA & IBRD countries) | Immunization, HepB3 (% of one-year-old children)
year value
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992 1.05923578
1993 1.3539415
1994 2.62405362
1995 4.07444122
1996 10.76644652
1997 13.35194221
1998 15.8103436
1999 17.68000626
2000 38.60740119
2001 51.10787063
2002 73.28035141
2003 81.10847086
2004 88.88160622
2005 91.20867225
2006 91.45701033
2007 95.13733006
2008 93.36663721
2009 93.06333209
2010 92.39774608
2011 90.50827264
2012 92.5677558
2013 92.94518962
2014 90.6347256
2015 91.18574999
2016 90.97864548
2017 93.37042787
2018 94.54848681
2019 95.10192546
2020 93.47049605
2021 93.86929977
2022 94.27904755

Europe & Central Asia (IDA & IBRD countries) | Immunization, HepB3 (% of one-year-old children)

Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Europe & Central Asia (IDA & IBRD countries)
Records
63
Source